Trial Design - Applied Clinical Trials

ADVERTISEMENT

Trial Design Zone
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more.

ADVERTISEMENT

Ethnobridging to Accelerate Global Drug Development
October 16, 2013
Multinational pharmaceutical companies are under intense financial and competitive pressures to make the drug development process more effective and efficient, and to expand into a greater number of international markets.
Shifting the Large Simple Trials Paradigm
July 1, 2014
Conducting Large Simple Trials to answer questions about "real-world" medical interventions is not a recent concept.
Objective Internal Monitoring Can Improve Trial Conduct, Results
July 1, 2014
Objective internal monitoring can help clinical trial sponsors transform a regulatory mandate into a valuable quality improvement tool.
Assess and Mitigate Risk in Clinical Trials
July 1, 2014
Regulatory authorities routinely inspect clinical trials, sites, sponsors, investigators, and other relevant parties to ensure compliance with good clinical practice guidelines.
Moving Toward Personalized Healthcare
June 26, 2014
PCORI underscored existing trends toward increasingly individualized and personalized medical care...
Articles By Category
Adaptive
Adaptive design, Phase 1–2, trial modification
Click Here for Articles

Postmarketing
Phase IV, postapproval, monitoring, safety
Click Here for Articles

Therapeutics
Pediatrics, oncology, diabetes, and other therapeutic areas
Click Here for Articles

Aptuit Offers Fast, Preliminary Hippocampal Screening Studies for CNS Drugs
ERT, Johns Hopkins University and the University of Washington Expand Study on Effects of Home-Health Monitoring on Exacerbations of Cystic Fibrosis
Coalition for Accelerating Standards and Therapies (CFAST) Announces a Resource for Parkinson's Disease Clinical Development
Verastem Enters Biomarker Agreement with LabCorp for Cancer Stem Cell Agent Companion Diagnostic
Biotie Therapies Selects Bracket's CDR System for Phase II Parkinson's Trial
Untitled Document
Click here